However, in light of the impact of p53 status on cytotoxicity and anticancer activity, since p53 is frequently dysregulated in colon cancer [57,58], our future investigations will be focused on the role of p53 of colon cancer cells treated with di-oxidated derivatives of diterpene atractyligenin amides. This evidence concerns the gene TP53 and malignant colon neoplasm.